Our study provides additional mechanistic insights into the potential molecular effectors that contribute to skeletal muscle pathology in SMA and suggests a role for the TWEAK/Fn14 pathway in the early stages of post-natal muscle development. The gene discussed is TNFRSF12A; the disease is proximal spinal muscular atrophy.